24 July 2020
Visiongain has launched a new report Operating Room Integration Market Report 2020-2030: Forecasts by Component (Software, and Service) Application (General Surgery Orthopaedic Surgery, Cardiovascular Surgery, Neurosurgery, Thoracic Surgery, and Others), by End-user (Hospitals, and Ambulatory Surgery Centers & Clinics) and by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.
An operating room integration system is precisely designed to minimize the congestion, simplify and streamline the operating room (OR) by consolidating patient data, access to audio, video, surgical lights, room lights, and controls for all of these devices at a central command station, permitting the surgical staff to carry out many of their tasks efficiently without needing to move around the OR. OR Integration also normally implicates suspending monitors and imaging modalities within the OR, eliminating trip-hazards caused by cabling and thereby allowing for easy access and visibility to surgical video. According to the The National Center for Biotechnology Information, operating rooms earn two-thirds of hospital incomes and also constitute for about 40% of hospital expenses and thus increase in the efficiency of operating rooms has an imperative influence on the financial and virtuous performance of hospitals.
The growing need for treatment of critical conditions such as cancer has led to rise in number of surgical procedures. This also results in a cumulative increase in number of OR procedures. The growth in geriatric population results in the rise in demand for surgeries. Moreover, the reconstructive surgeries or the plastic surgeries which are performed for cosmetic and aesthetic purposes, have also gained popularity. In addition, health awareness in the emerging economies leads to the rise in the number of surgeries. Thus, increase in number of surgeries majorly drives the operating room integration market.
Increase in cognizance about surgical interventions to treat conditions, such as obesity, has led medical device manufacturer to develop advanced operating room integration system. Furthermore, procedures employing surgical imaging, such as, endoscopy, are favoured both by medical practitioners and patients alike. Keyhole surgeries are now being executed and substituted for conventional surgical operations. For example, laparoscopy, which is a form of minimally invasive surgery, allows a surgeon to examine organs inside the abdomen and the pelvis without making large incisions. Across the world, patients prefer minimally invasive surgeries, as it gives them the benefit of doubt, pacifies their fears, provides them with a growth in sense of assurance and also has a higher success rate. Thus, growing popularity of minimally invasive procedures owing to associated benefits is anticipated to drive the market growth.
The Visiongain report analyst commented “that the rising number of ambulatory surgical centers (ASC) has led to the surge in the need of operating room integration. Moreover, the increase in the popularity and preference for minimally invasive surgery globally is anticipated to augment the growth of the market.”
The growing economies in the developing countries such as China, India, Indonesia, Thailand, and others and heavy investments in healthcare expenditure are expected to drive the market and create new opportunities during the forecast period. Also, the growing trend of medical tourism in Asia-Pacific countries is expected to contribute to this growth in the region.
However, the cost of operating room integration systems is high and are labelled as capital items by healthcare institutions. Hospitals and healthcare institutions need to consider various procurement processes and budget allocation considerations before purchasing the devices. Thus, the high cost and expenses involved in setting up a sophisticated operating room are the major factors obstructing the market growth.
The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include Stryker Corporation, STERIS, KARL STORZ, Olympus, Getinge, Alvo Medical, Skytron, Merivaara, Brainlab, TRILUX Medical, Caresyntax, Sony, Barco, Arthrex, and Richard Wolf.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.
18 January 2021
Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.
08 January 2021
The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.
07 January 2021
Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.